Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

AIM: This study tested for associations between SLCO1B1 polymorphisms and circulating estrogen levels in women with breast cancer treated with letrozole or exemestane. PATIENTS & METHODS: Postmenopausal women with hormone-receptor positive breast cancer were genotyped for SLCO1B1*5 (rs4149056) a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pharmacogenomics
Hoofdauteurs: Dempsey, Jacqueline M, Kidwell, Kelley M, Gersch, Christina L, Pesch, Andrea M, Desta, Zeruesenay, Storniolo, Anna Maria, Stearns, Vered, Skaar, Todd C, Hayes, Daniel F, Henry, N Lynn, Rae, James M, Hertz, Daniel L
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Future Medicine Ltd 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891932/
https://ncbi.nlm.nih.gov/pubmed/31190621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2019-0020
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items